Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist. In simple terms, they both ...

A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.

The popular diabetes drug Ozempic may cause temporary hair loss through rapid weight loss and nutritional changes. Medical ...

As appetite-suppressing drugs change the way people eat, businesses are adapting to GLP-1 users by offering smaller portions ...

Serena Williams, the 23-time Grand Slam champion, has faced a wave of online criticism accusing her of pursuing European ...

Recently, tennis legend Serena Williams opened up about using weight-loss medication, aiming to break the ‘stigma’ around ...

Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily ...

The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline ...

As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

Dubai: Serena Williams, the fiercest tennis athlete of our time, has built a career out of smashing stereotypes and ...

When Hope Lancaster Colquhoun was prescribed Mounjaro and instantly shed the pounds, the jab felt like a 'lifeline'. But her ...

Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer discounted access to competing products. ETFs with high concentration in HIMS may face risks and losses.